Altamira Therapeutics (OTCQB: CYTOF) reports 2024 financial results, focuses on expanding RNA delivery technology.

Bermuda-based Altamira Therapeutics Ltd. (OTCQB: CYTOF) announced its business update and disclosed its financial performance for the full year of 2024. Altamira focuses on developing and marketing RNA delivery technology for non-liver targets.